The DOI matches its Crossref record; 111 of the 116 references it cites were found in a registry or an index.
Central Hypothyroidism: Pathogenic, Diagnostic, and Therapeutic Challenges
Abstract
CONTEXT: Central hypothyroidism (CH) is a particular hypothyroid condition due to an insufficient stimulation by TSH of an otherwise normal thyroid gland. This condition raises several challenges for clinicians; therefore, a review of the most relevant findings on CH epidemiology, pathogenesis, and clinical management has been performed. METHODOLOGY: The relevant papers were selected by a PubMed search using appropriate key words. MAIN FINDINGS: CH can be the consequence of various disorders affecting either the pituitary gland or the hypothalamus, but most frequently affecting both of them. CH is about 1000-fold rarer than primary hypothyroidism. Except for the neonatal CH due to biallelic TSHβ mutations, the thyroid hormone defect is rarely as profound as can be observed in some primary forms. In contrast with primary hypothyroidism, CH is most frequently characterized by low/normal TSH levels, and adequate thyroid hormone replacement is associated with the suppression of residual TSH secretion. Thus, CH often represents a clinical challenge because physicians cannot rely on the systematic use of the "reflex TSH strategy." The clinical management of CH is further complicated by the frequent combination with other pituitary deficiencies and their substitution.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several other drugs (e.g., glucocorticoids, anti-epileptics, somatostatin) have transient or controversial TSH-suppressive effects [1, 38] (see Table 3).”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [1]
In the citing paper
“However, a major limitation remains—the lack of assay specificity to distinguish between the bioactive TSH secreted in primary hypothyroidism versus the biologically inactive TSH isoforms typically secreted in central hypothyroidism.”
In the citing paper
“Secondary and tertiary hypothyroidism are often referred to as central hypothyroidism, and both central and extrathyroidal hypothyroidism account for less than 1% of cases worldwide.54”
From Hypothyroidism (2024) · cites this paper as [54]
In the citing paper
“Manifestations of CeH are similar to those of primary hypothyroidism, but they can be masked by coexistent MPHD [1, 24, 25].”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [1]
In the citing paper
“This condition is the consequence of anatomic or functional disorders of the pituitary gland (secondary hypothyroidism) or the hypothalamus (tertiary hypothyroidism) causing variable alterations of TSH secretion [1, 2].”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [1]
12 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279
Cooper, D. S., & Biondi, B. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60276-6 · Cited by 1,039
Update of Newborn Screening and Therapy for Congenital Hypothyroidism
American Academy of Pediatrics, Rose, S. R., and the Section on Endocrinology and Committee on Genetics, American Thyroid Association, Brown, R. S., and the Public Health Committee, & Lawson Wilkins Pediatric Endocrine Society (2006) · Pediatrics · doi:10.1542/peds.2006-0915 · Cited by 798
Andersen, S., Pedersen, K. M., Bruun, N. H., & Laurberg, P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8165 · Cited by 686
Hypothalamic-pituitary dysfunction after radiation for brain tumors
Constine, L. S., Woolf, P. D., Cann, D., Mick, G., McCormick, K., Raubertas, R. F., & Rubin, P. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280203 · Cited by 619
Caturegli, P., Newschaffer, C., Olivi, A., Pomper, M. G., Burger, P. C., & Rose, N. R. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0011 · Cited by 588
Self-formation of functional adenohypophysis in three-dimensional culture
Suga, H., Kadoshima, T., Minaguchi, M., Ohgushi, M., Soen, M., Nakano, T., Takata, N., Wataya, T., Muguruma, K., Miyoshi, H., et al. (2011) · Nature · doi:10.1038/nature10637 · Cited by 498
Thyrotropin-Secreting Pituitary Tumors*
BECK-PECCOZ, P., BRUCKER-DAVIS, F., PERSANI, L., SMALLRIDGE, R. C., & WEINTRAUB, B. D. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-6-610 · Cited by 491
Self-citationMechanisms behind the non-thyroidal illness syndrome: an update
Warner, M. H., & Beckett, G. J. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0412 · Cited by 432
A Mutation in the Thyroid Hormone Receptor Alpha Gene
Bochukova, E., Schoenmakers, N., Agostini, M., Schoenmakers, E., Rajanayagam, O., Keogh, J. M., Henning, E., Reinemund, J., Gevers, E., Sarri, M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110296 · Cited by 379
Research works printed but not linked: 1
- Persani, 2012, Central hypothyroidism, 560
Cited by
Global epidemiology of hyperthyroidism and hypothyroidism
Taylor, P. N., Albrecht, D., Scholz, A., Gutierrez-Buey, G., Lazarus, J. H., Dayan, C. M., & Okosieme, O. E. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.18 · Cited by 1,552
Chaker, L., Bianco, A. C., Jonklaas, J., & Peeters, R. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30703-1 · Cited by 1,159
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study
Wu, Y.-L., Lin, Z.-J., Li, C.-C., Lin, X., Shan, S.-K., Guo, B., Zheng, M.-H., Li, F., Yuan, L.-Q., & Li, Z.-H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01333-7 · Cited by 476
“These diseases include obesity,(3) type 2 diabetes (T2D),(4) nonalcoholic fatty liver disease (NAFLD),(5) osteoporosis,(6) gout,(7) hyperthyroidism(8) and hypothyroidism.(9) Diabetes has become the ninth major cause of death worldwide.”
BackgroundHypothyroidism in Context: Where We’ve Been and Where We’re Going
Chiovato, L., Magri, F., & Carlé, A. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01080-8 · Cited by 459
Chaker, L., Razvi, S., Bensenor, I. M., Azizi, F., Pearce, E. N., & Peeters, R. P. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00357-7 · Cited by 330
Higham, C. E., Johannsson, G., & Shalet, S. M. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30053-8 · Cited by 267
Treatment with thyroid hormone
Biondi, B., & Wartofsky, L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1083 · Cited by 259
“Some mutations in genes regulating pituitary gland development may be responsible for familial hypopituitarism (81).”
BackgroundInfluentialInterferences With Thyroid Function Immunoassays: Clinical Implications and Detection Algorithm
Favresse, J., Burlacu, M.-C., Maiter, D., & Gruson, D. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00119 · Cited by 258
Persani, L., Brabant, G., Dattani, M., Bonomi, M., Feldt-Rasmussen, U., Fliers, E., Gruters, A., Maiter, D., Schoenmakers, N., & van Trotsenburg, A. S. P. (2018) · European Thyroid Journal · doi:10.1159/000491388 · Cited by 222
Self-citationMazziotti, G., Frara, S., & Giustina, A. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00005 · Cited by 181
Feldt-Rasmussen, U., Effraimidis, G., & Klose, M. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111173 · Cited by 170
“Nevertheless, the analytical methods are unfortunately still characterized by unpredictable uncertainties, flaws and confounders (Table 1) (Baloch et al., 2003; Feldt-Rasmussen, 2020; Feldt-Rasmussen and Klose, 2016; Grebe, 2019; Persani, 2012; Persani and Beck-Peccoz, 2021; Stockigt, 2011).”
MethodJanssen, B. G., Saenen, N. D., Roels, H. A., Madhloum, N., Gyselaers, W., Lefebvre, W., Penders, J., Vanpoucke, C., Vrijens, K., & Nawrot, T. S. (2017) · Environmental Health Perspectives · doi:10.1289/ehp508 · Cited by 143
Raff, H., Sharma, S. T., & Nieman, L. K. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130035 · Cited by 141
Taylor, P. N., Medici, M. M., Hubalewska-Dydejczyk, A., & Boelaert, K. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01614-3 · Cited by 128
Recent advances in central congenital hypothyroidism
Schoenmakers, N., Alatzoglou, K. S., Chatterjee, V. K., & Dattani, M. T. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0341 · Cited by 125
“A recent study demonstrated that more than 50% of children with CCH will have moderate or severe hypothyroidism, such that the potential neurological sequelae of delayed diagnosis should not be underestimated (Persani 2012, ZwavelingSoonawala et al. 2015).”
BackgroundHypothyroidism and Thyroiditis
Brent, G. A., & Davies, T. F. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00013-4 · Cited by 126
Thyrotropin secretion patterns in health and disease
Roelfsema, F., & Veldhuis, J. D. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1076 · Cited by 113
“Central hypothyroidism can be caused by congenital disorders associated with mutations of pituitary transcription-factor genes, causing various defects in pituitary differentiation, eg, POU1F1, PROP1, HESX1, LHX3, LHX4, and LEPR, thereby leading to insufficiency of 1 or more pituitary functions (184, 185).”
BackgroundThyroid hormone therapy for hypothyroidism
Biondi, B., & Cooper, D. S. (2019) · Endocrine · doi:10.1007/s12020-019-02023-7 · Cited by 119
Congenital hypothyroidism: insights into pathogenesis and treatment
Cherella, C. E., & Wassner, A. J. (2017) · International Journal of Pediatric Endocrinology · doi:10.1186/s13633-017-0051-0 · Cited by 106
“…bioactivity of TSH. Congenital hypothyroidism of central origin is rare: early estimates of its incidence were between 1:29,000 and 1:110,000 [30 – 32], although more recent data from the Netherlands suggest that it may occur in as many as 1:16,000 newborns and could represent up to 13% of cases…”
BackgroundVan Uytfanghe, K., Ehrenkranz, J., Halsall, D., Hoff, K., Loh, T. P., Spencer, C. A., Köhrle, J., & ATA Thyroid Function Tests Writing Group (2023) · Thyroid® · doi:10.1089/thy.2023.0169 · Cited by 100
Pediatric Hypothyroidism: Diagnosis and Treatment
Wassner, A. J. (2017) · Pediatric Drugs · doi:10.1007/s40272-017-0238-0 · Cited by 116
Mutations in TBL1X Are Associated With Central Hypothyroidism
Heinen, C. A., Losekoot, M., Sun, Y., Watson, P. J., Fairall, L., Joustra, S. D., Zwaveling-Soonawala, N., Oostdijk, W., van den Akker, E. L. T., Alders, M., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2531 · Cited by 92
“CeH may be caused by congenital or acquired disorders of the pituitary gland or hypothalamus (1).”
BackgroundIGSF1 Deficiency: Lessons From an Extensive Case Series and Recommendations for Clinical Management
Joustra, S. D., Heinen, C. A., Schoenmakers, N., Bonomi, M., Ballieux, B. E. P. B., Turgeon, M.-O., Bernard, D. J., Fliers, E., van Trotsenburg, A. S. P., Losekoot, M., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3880 · Cited by 91
“Male and female adults who started treatment after diagnosis reported major improvements in energy levels, as previously described in other hidden forms of central hypothyroidism (23), although long-term results in our patients are unavailable.”
BackgroundSelf-citationLöf, C., Patyra, K., Kuulasmaa, T., Vangipurapu, J., Undeutsch, H., Jaeschke, H., Pajunen, T., Kero, A., Krude, H., Biebermann, H., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0016 · Cited by 81
Genetics of primary congenital hypothyroidism—a review
Kostopoulou, E., Miliordos, K., & Spiliotis, B. E. (2021) · HORMONES · doi:10.1007/s42000-020-00267-x · Cited by 96
Initial evaluation of thyroid dysfunction - Are simultaneous TSH and fT4 tests necessary?
Schneider, C., Feller, M., Bauer, D. C., Collet, T., da Costa, B. R., Auer, R., Peeters, R. P., Brown, S. J., Bremner, A., O'Leary, P. C., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196631 · Cited by 76
Epidemiology, Types, Causes, Clinical Presentation, Diagnosis, and Treatment of Hypothyroidism
Zamwar, U. M., & Muneshwar, K. N. (2023) · Cureus · doi:10.7759/cureus.46241 · Cited by 113
“[22].”
BackgroundThe diagnosis and management of central hypothyroidism in 2018
Persani, L., Cangiano, B., & Bonomi, M. (2019) · Endocrine Connections · doi:10.1530/ec-18-0515 · Cited by 64
Self-citationDíaz, A., & Diaz, E. G. L. (2014) · Pediatrics in Review · doi:10.1542/pir.35.8.336 · Cited by 65
Endocrine Disorder in Patients With Craniopharyngioma
Zhou, Z., Zhang, S., & Hu, F. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.737743 · Cited by 48
Klose, M., Marina, D., Hartoft-Nielsen, M.-L., Klefter, O., Gavan, V., Hilsted, L., Rasmussen, Å. K., & Feldt-Rasmussen, U. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1610 · Cited by 53
Keer, S. E., Cohen, K. E., May, C. M., Hu, Y., McMenamin, S. K., & Hernandez, L. P. (2019) · The Anatomical Record · doi:10.1002/ar.24139 · Cited by 54
“Hypo- and hyperthyroidism can be caused by a variety of disorders (Devdhar et al., 2007; Persani, 2012; De Leo et al., 2016), and cause wide-ranging systemic effects in vertebrates.”
BackgroundRelational Stability in the Expression of Normality, Variation, and Control of Thyroid Function
Hoermann, R., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00142 · Cited by 48
Fallahi, P., Ferrari, S. M., Ruffilli, I., Ragusa, F., Biricotti, M., Materazzi, G., Miccoli, P., & Antonelli, A. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1227782 · Cited by 48
“or the anterior pituitary gland, is less frequent [16].”
BackgroundChronic endocrine consequences of traumatic brain injury — what is the evidence?
Klose, M., & Feldt-Rasmussen, U. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.103 · Cited by 41
Consequences of undertreatment of hypothyroidism
Feldt‐Rasmussen, U., Effraimidis, G., Bliddal, S., & Klose, M. (2023) · Endocrine · doi:10.1007/s12020-023-03460-1 · Cited by 61
Lv, L., Jiang, Y., Yin, S., Hu, Y., Chen, C., Ma, W., Jiang, S., & Zhou, P. (2019) · Endocrine · doi:10.1007/s12020-019-02029-1 · Cited by 47
The multiple genetic causes of central hypothyroidism
Persani, L., & Bonomi, M. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.04.003 · Cited by 46
“Please cite this article in press as: Persani L, Bonomi MThe multiple genetic causes of central hypothyroidism, Best Practice& Research Clinical Endocrinology&Metabolism (2017), http://dx.”
MethodSelf-citationGarcía, M., Barrio, R., García-Lavandeira, M., Garcia-Rendueles, Á. R., Escudero, A., Díaz‐Rodriguez, E., del Blanco, D. G., Fernández, A., de Rijke, Y. B., Vallespín, E., et al. (2017) · Scientific Reports · doi:10.1038/srep42937 · Cited by 46
Regulatory aspects of the human hypothalamus-pituitary-thyroid axis
Roelfsema, F., Boelen, A., Kalsbeek, A., & Fliers, E. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.09.004 · Cited by 49
Central hypothyroidism and its role for cardiovascular risk factors in hypopituitary patients
Feldt-Rasmussen, U., & Klose, M. (2016) · Endocrine · doi:10.1007/s12020-016-1047-x · Cited by 43
“Note that serum TSH levels can be low, normal, or high (Reproduced with permission from Persani et al. [19]) Endocrine (2016) 54:15–23 17”
BackgroundMaciel, L. M. Z., Kimura, E. T., Nogueira, C. R., Mazeto, G. M. F. D. S., Magalhães, P. K. R., Nascimento, M. L., Nesi-França, S., & Vieira, S. E. (2013) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302013000300004 · Cited by 65
Appelman‐Dijkstra, N. M., Malgo, F., Neelis, K. J., Coremans, I. E. M., Biermasz, N. R., & Pereira, A. M. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.08.018 · Cited by 42
Gluvic, Z. M., Obradovic, M. M., Stewart, A. J., Essack, M., Pitt, S. J., Samardzic, V. S., Šoškić, S., Gojobori, T., & Isenović, E. R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.758043 · Cited by 47
“LT4-dose tapering is more complex in patients with secondary and tertiary hypothyroidism as the fT4 levels, which is the basis of how the quality of LT4 dosing is assessed, are less flexible (49, 60).”
BackgroundMutations in IRS4 are associated with central hypothyroidism
Heinen, C. A., de Vries, E. M., Alders, M., Bikker, H., Zwaveling-Soonawala, N., van den Akker, E. L. T., Bakker, B., Hoorweg-Nijman, G., Roelfsema, F., Hennekam, R. C., et al. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2017-105113 · Cited by 38
Dubbs, S. B., & Spangler, R. (2014) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2013.12.003 · Cited by 45
TRH Action Is Impaired in Pituitaries of Male IGSF1-Deficient Mice
Turgeon, M., Silander, T. L., Doycheva, D., Liao, X.-H., Rigden, M. D., Ongaro, L., Zhou, X., Joustra, S. D., Wit, J. M., Wade, M. G., et al. (2017) · Endocrinology · doi:10.1210/en.2016-1788 · Cited by 39
Sanctis, V. D., Soliman, A. T., Canatan, D., Yassin, M. A., Daar, S., Elsedfy, H., Maio, S. D., Raiola, G., Corrons, J.-L. V., & Kattamis, C. (2019) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2019.029 · Cited by 53
Research progress of radiation-induced hypothyroidism in head and neck cancer
Zhou, L., Chen, J., Tao, C., Chen, M., Yu, Z.-H., & Chen, Y. (2020) · Journal of Cancer · doi:10.7150/jca.48587 · Cited by 39
“Central and peripheral hypothyroidism is rare, with an incidence of less than 1% [5].”
BackgroundCentral hypothyroidism in adults: better understanding for better care
Grunenwald, S., & Caron, P. (2015) · Pituitary · doi:10.1007/s11102-014-0559-8 · Cited by 35
“Secreting and non-secreting pituitary macroadenomas are responsible for more than 50 % of CH cases [2] and they are often associated with more general anterior pituitary insufficiency, caused either by compression or”
BackgroundInfluentialGarcía, M., González de Buitrago, J., Jiménez-Rosés, M., Pardo, L., Hinkle, P. M., & Moreno, J. C. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3977 · Cited by 33
Zhan, M., Chen, G., Pan, C., Gu, Z., Zhao, S., Liu, W. Y., Wang, H.-N., Ye, X.-P., Xie, H.-J., Yu, S.-S., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu250 · Cited by 32
Spatial and temporal expression of immunoglobulin superfamily member 1 in the rat
Joustra, S. D., Meijer, O. C., Heinen, C. A., Mol, I. M., Laghmani, E. H., Sengers, R. M. A., Carreno, G., van Trotsenburg, A. S. P., Biermasz, N. R., Bernard, D. J., et al. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0204 · Cited by 32
“It is, however, unknown whether this central hypothyroidism is caused by a defect in the hypothalamus, pituitary gland, or both, since no diagnostic tool (including the TRH stimulation test) can determine this with certainty (Persani 2012).”
BackgroundApproach to the Patient With Immune Checkpoint Inhibitor–Associated Endocrine Dysfunction
Wright, J. J., & Johnson, D. B. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac689 · Cited by 33
Tirabassi, G., Muti, N. D., Corona, G., Maggi, M., & Balercia, G. (2013) · International Journal of Endocrinology · doi:10.1155/2013/816740 · Cited by 32
Anatomy and Physiology of the Thyroid Gland
Stathatos, N. (2019) · Springer eBooks · doi:10.1007/978-3-319-72102-6_1 · Cited by 38
Central Hypothyroidism in Children
García, M., Fernández, A., & Moreno, J. C. (2014) · Endocrine development · doi:10.1159/000363157 · Cited by 33
Curtò, L., & Trimarchi, F. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0487-8 · Cited by 30
“Regarding evaluation of the hypothalamic–pituitary– thyroid (HPT) axis function, detection of low levels of FT4 with low or normal TSH levels is sufficient to make a diagnosis of CH [46] (Table 2).”
BackgroundCentral regulation of the hypothalamo–pituitary–thyroid (HPT) axis
Fliers, E., Boelen, A., & van Trotsenburg, A. S. P. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59602-4.00009-5 · Cited by 34
Thyroid hormone resistance: mechanisms and therapeutic development
Yao, B., Yang, C., Pan, C., & Li, Y. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111679 · Cited by 26
Lawson, S. A., Horne, V. E., Golekoh, M. C., Hornung, L. N., Burns, K. C., Fouladi, M., & Rose, S. R. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.27631 · Cited by 27
Neonatal Hypopituitarism: Approaches to Diagnosis and Treatment
Kurtoğlu, S., Özdemi̇r, A., & Hatipoğlu, N. (2018) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.0036 · Cited by 26
“Dose deficiency is determined by free T4 and overdose by free T3 level (71).”
Thyroid Function and Nutrient Status in the Athlete
Larson‐Meyer, D. E., & Gostas, D. E. (2020) · Current Sports Medicine Reports · doi:10.1249/jsr.0000000000000689 · Cited by 32
“For example, studies in patients with HT who were being treated with thyroid replacement (levothyroxine) found that daily supplementation with 2000 IU for 6 months increased serum 25-OH concentrations and reduced titers of antibodies to TPO and thyroglobulin (25).”
BackgroundTreatment of congenital thyroid dysfunction: Achievements and challenges
Krude, H., Kühnen, P., & Biebermann, H. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.04.004 · Cited by 30
Risks of suboptimal and excessive thyroid hormone replacement across ages
Feldt-Rasmussen, U., Effraimidis, G., Bliddal, S., & Klose, M. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02229-7 · Cited by 23
Mukai, K., Kitamura, T., Tamada, D., Murata, M., Otsuki, M., & Shimomura, I. (2016) · Endocrine Journal · doi:10.1507/endocrj.ej16-0168 · Cited by 29
Treatment of hypopituitarism in patients receiving antiepileptic drugs
Paragliola, R. M., Prete, A., Kaplan, P. W., Corsello, S. M., & Salvatori, R. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70081-6 · Cited by 22
Qiu, Y., Hu, Y., Xing, Z., Fu, Q., Zhu, J., & Su, A. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-046607 · Cited by 24
de Vries, F., Lobatto, D. J., Bakker, L. E. H., van Furth, W. R., Biermasz, N. R., & Pereira, A. M. (2019) · Endocrine · doi:10.1007/s12020-019-02094-6 · Cited by 21
Tirabassi, G., Muti, N. D., Gioia, A., Biagioli, A., Lenzi, A., & Balercia, G. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0052-2 · Cited by 20
Zwaveling‐Soonawala, N., van Trotsenburg, A. S. P., & Verkerk, P. H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01577 · Cited by 23
Hyperprolactinemia in clinical non-functional pituitary macroadenomas: A STROBE-compliant study
Lyu, L., Yin, S., Hu, Y., Chen, C., Jiang, Y., Yu, Y., Ma, W., Wang, Z., Jiang, S., & Zhou, P. (2020) · Medicine · doi:10.1097/md.0000000000022673 · Cited by 20
“Central hypothyroidism was diagnosed in accordance with low circulating FT4 within low or normal TSH level.([21,22]) Central hypoadrenocorticism was verified by decreased serum cortisol.”
Thyroid disorders in elderly: A comprehensive review
Thiruvengadam, S., & Luthra, P. (2021) · Disease-a-Month · doi:10.1016/j.disamonth.2021.101223 · Cited by 24
Candido, A. C., Vieira, A. A., Ferreira, E. D. S., Moreira, T. R., Franceschini, S. D. C. C., & Cotta, R. M. M. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03401-5 · Cited by 19
“Hypothyroxinemia, on the other, is defined when the maternal TSH concentration is adequate and that of FT4 is lower than the reference interval [32].”
BackgroundBornikowska, K., Gietka-Czernel, M., Raczkiewicz, D., Glinicki, P., & Zgliczyński, W. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10225233 · Cited by 17
“reported that about half of the target LT4 substitutive dose is sufficient to suppress TSH secretion in about 80% of CH patients, even though serum FT4 levels are still in the hypothyroid range in most cases [38].”
BackgroundCompendium of causative genes and their encoded proteins for common monogenic disorders
Apgar, T. L., & Sanders, C. R. (2021) · Protein Science · doi:10.1002/pro.4183 · Cited by 23
Hypothalamic-Pituitary-Thyroid Axis Perturbations in Male Mice by CNS-Penetrating Thyromimetics
Ferrara, S. J., BOURDETTE, D. N., & Scanlan, T. S. (2018) · Endocrinology · doi:10.1210/en.2018-00065 · Cited by 17
Clinical investigation of pituitary incidentalomas: A two-center study
Ishii, K., Abe, I., Kameda, W., Sugimoto, K., Morinaga, Y., Miiko, I. T. O., Takashi, Y., Abe, M., Hada, Y., Takase, K., et al. (2019) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2019.01083 · Cited by 17
“The diagnosis of hormonal deficiency was performed in accordance with previous reports (20-23).”
MethodOto, Y., Muroya, K., Hanakawa, J., Asakura, Y., & Adachi, M. (2015) · Thyroid Research · doi:10.1186/s13044-015-0023-5 · Cited by 16
Is beta-carotene consumption associated with thyroid hormone levels?
Far, B. F., Lomer, N. B., Gharedaghi, H., Sahrai, H., Mahmoudvand, G., & Rouzbahani, A. K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1089315 · Cited by 18
Tirabassi, G., Muti, N. D., Corona, G., Maggi, M., & Balercia, G. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12493 · Cited by 16
Hypothyroidism and Thyroiditis
Brent, G. A., & Weetman, A. P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00013-7 · Cited by 23
Mortality in Children With Early-Detected Congenital Central Hypothyroidism
Zwaveling-Soonawala, N., Naafs, J. C., Verkerk, P. H., & van Trotsenburg, A. S. P. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00629 · Cited by 15
Jiang, T., Yang, X., Wu, B., Tao, R., Chen, R., Jin, L., Sun, D., & Weng, H. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1661211 · Cited by 19
“Epidemiological studies estimate that the global prevalence of overt hypothyroidism is approximately 4.6% in the United States and 5% in Europe, with even higher rates observed in iodine-deficient regions (Persani, 2012).”
InfluentialDraft of the clinical recommendations for diagnosis and treatment of hypothyroidism
Fadeev, V. V., Моргунова, Т. Б., Mel'nichenko, G. A., & Dedov, I. I. (2021) · Clinical and experimental thyroidology · doi:10.14341/ket12702 · Cited by 16
Central Hypothyroidism and Novel Clinical Phenotypes in Hemizygous Truncation of TBL1X
García, M., Bonis, A. C. B., Jiménez, P., Retolaza, I. R., Villalobos, A. O., Vallespín, E., del Pozo, Á., Millán, J. M. S., Casado, I. G., & Moreno, J. C. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00144 · Cited by 18
Glynn, N., Halsall, D. J., Boran, G. P., Cook, P. R., McDermott, J. H., Smith, D., Tormey, W. P., Thompson, C. J., O’Gorman, D. J., McKenna, M. J., et al. (2021) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2021.101393 · Cited by 16
Hirata, Y., Fukuoka, H., Iguchi, G., Iwahashi, Y., Fujita, Y., Hari, Y., Iga, M., Nakajima, S., Nishimoto, Y., Mukai, M., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0130 · Cited by 14
Dong, S., Liu, Q., Jiang, M., Ma, Q., Huang, Q., Liu, T., Li, Y., Ni, L., & Shi, Y. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115045 · Cited by 17
Wassner, A. J., Cohen, L. E., Hechter, E., & Dauber, A. N. (2013) · Hormone Research in Paediatrics · doi:10.1159/000350013 · Cited by 14
Necrotizing myopathy caused by central hypothyroidism
Tiniakou, E., & Mammen, A. L. (2015) · Muscle & Nerve · doi:10.1002/mus.24637 · Cited by 14
Endocrine Diseases and Disorders of Thyroid Function in Newborns
Ghirri, P., Balsamo, A., Ciantelli, M., Cavarzere, P., Cicognani, A., Boldrini, A., & Cassio, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-29489-6_259 · Cited by 13
Gender differences in macroprolactinomas: a single centre experience
Khare, S., Lila, A. R., Patt, H., Yerawar, C. G., Goroshi, M., Bandgar, T., & Shah, N. S. (2015) · Endocrine Connections · doi:10.1530/ec-15-0105 · Cited by 14
Interactions between hypothalamic pituitary thyroid axis and other pituitary dysfunctions
Feldt-Rasmussen, U., Klose, M., & Benvenga, S. (2018) · Endocrine · doi:10.1007/s12020-018-1738-6 · Cited by 12
Wang, X., Zhang, W., & Zhou, S. (2024) · Phytotherapy Research · doi:10.1002/ptr.8208 · Cited by 15
“…hypothyroidism and hyperthyroidism commonly result from issues within the thyroid gland itself, but in rare cases, they may stem from conditions in the hypothalamus or pituitary (central hypothyroidism) or external factors like struma ovarii or functional thyroid cancer metastases (Persani, 2012).”
Hypothyroidism Affects Uterine Function via the Modulation of Prostaglandin Signaling
Kowalczyk‐Zieba, I., Staszkiewicz‐Chodor, J., Boruszewska, D., Łukaszuk, K., Jaworska, J., & Wocławek-Potocka, I. (2021) · Animals · doi:10.3390/ani11092636 · Cited by 14
“The lifetime risk of overt hypothyroidism is around 5%, and this disease is usually preceded by subclinical hypothyroidism, which has an even higher prevalence (estimated to be up to 9%) [52].”
BackgroundInfluentialKeen, F., Chalishazar, A., Mitchem, K., Dodd, A., & Kalhan, A. (2022) · European Thyroid Journal · doi:10.1530/etj-21-0119 · Cited by 15
Hypothyroidism and Myxedema Coma
Wiersinga, W. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00088-3 · Cited by 16
Pituitary deficiencies related to optic nerve hypoplasia and visual acuity
Murray, A., Schwartz, T. L., Hornung, L. N., & Lawson, S. A. (2024) · Clinical Endocrinology · doi:10.1111/cen.15125 · Cited by 11
Metadata
- Authors
- Persani, L.
- Affiliations
- University of Milan (IT)
- Corresponding author
- Persani, Luca
- ORCID
- Persani, Luca
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-09-01
- Volume
- 97
- Issue
- 9
- Pages
- 3068-3078
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2004260518
- Semantic Scholar
- 4548bf36df8fba0df7b332473f63c79f41e5cb60
- Cited by
- 295
- References
- 116
- Citations by year
- 2026: 14 · 2025: 28 · 2024: 18 · 2023: 21 · 2022: 22 · 2021: 26 · 2020: 16 · 2019: 32 · 2018: 25 · 2017: 20 · 2016: 21 · 2015: 18 · 2014: 23 · 2013: 9
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Università degli Studi di Milano
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- central hypothyroidism, TSH deficiency, pituitary disorders, hypothalamic disorders, neonatal hypothyroidism, thyroid hormone replacement, TSH suppression, pituitary hormone deficiency
- MeSH terms
- Humans, Hypothyroidism, Thyroid Hormones, Thyrotropin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.